Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Large-Cell, Anaplastic

Clinical trial condition

Lymphoma, Large-Cell, Anaplastic

Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.

289 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Anaplastic trial results

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
Locations: A.Z. St. Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 24 locations

View Trial Details

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations: Jennie Stuart Medical Center Hopkinsville, Kentucky, United States

Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States

Erlanger Health System Chattanooga, Tennessee, United States

Tennessee Plateau Oncology Crossville, Tennessee, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Breast Cancer, +67 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

NCT00003215

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Allgemeines Krankenhaus der Stadt Wien Vienna, Austria

Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany

Saint Savvas Cancer Hospital of Athens Athens, Greece

European Institute of Oncology Milan, Italy

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

NCT00019513

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +84 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00734890

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +67 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

NCT00019019

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +114 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Medical Oncology Clinical Research Unit Bethesda, Maryland, United States

View Trial Details

Completed

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

NCT00031941

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details